Salute e Benessere

Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab…

Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 phase 1/2 trial evaluating the preliminary efficacy and safety of epcoritamab in patients with non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL)DLBCL is an aggressive subtype of NHL and accounts for approximately 30 percent of all global casesIf approved, epcoritamab (TEPKINLY ® )would become the first and only subcutaneous bispecific...
Nasdaq GlobeNewswire
21/07/2023

Curium Announces Publication of [18F]DCFPyL Versus [18F]Fluoromethylcholine…

18 F] piflufolastat ([ 18 F]DCFPyL) versus [ 18 F]fluoromethylcholine PET/CT in patients with first biochemical recurrence of prostate cancer. The results of the PYTHON trial were published online ahead of print in theEuropean Journal of Nuclear Medicine and Molecular Imagingin June 2023.Today's announcement follows the May 2023 recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency to grant a marketing authorization for PYLCLARI ®...
Nasdaq GlobeNewswire
21/07/2023

Lindab's Interim Report January - June 2023: Ventilation shows strength and…

January - June 2023 January -June 2023 1) Adjusted operating profit/operating margin does not include significant one-off items and restructuring costs. Lindab's President and CEO,Ola Ringdahl, comments: "Lindab's sales and earnings developed well during the second quarter even though the economic climate was challenging. The assessment is that demand in the ventilation market has stabilised. Sales within Ventilation Systems continued to grow and the operating margin for...
PR Newswire
21/07/2023

Idorsia announces a cost reduction initiative to be implemented by the end of…

Ad hoc announcement pursuant to Art. 53 LR In order to give Idorsia the necessary time to realize commercial success – any funds that are raised must be prioritized on activities to maximize their return in the near-term.The cost reduction initiative is dependent on a full portfolio review, potential out-licensing deals, and an employee representative consultation in Switzerland.The company is launching the initiative with the target of a reduction in cash-burn at headquarters by...
Nasdaq GlobeNewswire
21/07/2023

Diabetic Peripheral Neuropathy Market Growing at a CAGR of ~6% by 2032 |…

Key Takeaways from the Diabetic Peripheral Neuropathy Market Report Key Takeaways from the Diabetic Peripheral Neuropathy Market Report Discover which therapies are expected to grab the major diabetic peripheral neuropathy market share @Diabetic Peripheral Neuropathy Market Report Diabetic Peripheral Neuropathy Overview Diabetic peripheral neuropathy is described as the presence of peripheral nerve dysfunction signs and symptoms in diabetics. It affects about half of all...
PR Newswire
20/07/2023

Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, July20, 2023(GLOBE NEWSWIRE) --Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website: www.nanobiotix.com Date Number of SharesOutstanding Total number of voting rightsTotal voting rights,...
Nasdaq GlobeNewswire
20/07/2023

ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical…

®(loncastuximab tesirine-lpyl) and rituximab (Lonca-R) in unfit or frail patients with previously untreated diffuse large B-cell lymphoma (DLBCL). Given the challenges of defining the addressable segment of the difficult-to-treat unfit or frail DLBCL patient population, including many patients with significant active underlying co-morbidities, the benefit-risk profile does not support continuation of the LOTIS-9 trial. Following a meeting yesterday, the U.S. Food and Drug Administration...
Nasdaq GlobeNewswire
20/07/2023

The US Continuing Medical Education Market to be Worth $4.23 Billion by 2028, A…

The continuous and rapid evolution of technologies in the last few years has radically transformed the way people or healthcare professionals communicate, process knowledge, and seek information in the healthcare industry. Continuing Medical Education (CME) is no exception in this evolution. Even though CME is not a preferred learning medium, healthcare workers increasingly seek continuing education through digital channels and new technologies as they offer convenient access, personalization…
PR Newswire
20/07/2023

Guerbet: First-half 2023 revenue

First-half 2023 revenue Acceleration of activityHalf-year revenue: €378.6 million, up +2.8% at CER 1, with a strong acceleration of activity in Q2, at +6.7%Very dynamic sales in Asia (+16.6% in H1 at CER) and EMEA (+7.8%), but down in the Americas (-15.3%), as expected Financial objectives confirmed2023 revenue growth of more than 5% on a like-for-like basis and at CERRestated EBITDA margin rate 2 : around 11% in 2023, before a return in 2024 to a higher...
Nasdaq GlobeNewswire
20/07/2023

PADAGIS ANNOUNCES THE ACQUISITION OF 17,000 SQUARE METER FACILITY IN YERUCHAM…

In parallel to this transaction, Padagis is seeking top talent to work at its Yerucham, Israel and Minneapolis, Minnesota facilities. If you are interested in creating a real impact at a leading, innovative pharmaceutical company, visit the Padagis careers page for a full list of open roles: padagis.co.il/career/ for Israel positions and www.padagis.com/careers for U.S. positions. In parallel to this transaction, Padagis is seeking top talent to work at its Yerucham,IsraelandMinneapolis,...
PR Newswire
20/07/2023

Adria Dental Group expands to Slavonia: CEE's biggest dental group invests in…

"We saw this investment as a major opportunity for our further growth and development. Being part of the group that combines the knowhow, latest cutting-edge technology, and standardized service across its clinics is an important step forward for our team and for our clinic. We are pleased that ADG has recognized our expertise and our dedication. We have strived towards further strengthening of our market position and cooperating with the biggest professionals in the industry, and with…
PR Newswire
20/07/2023

Phenomenex Introduces New HPLC Column for Ionic Pesticides Analyses in…

The Luna Polar Pesticides HPLC column is designed to help resolve the most common challenges food safety analysts encounter daily: robust determination of analytes due to matrices complexity and polarity, lengthy process due to the high number of injections needed for column conditioning, time-consuming sample preparation due to the need for derivatization, and the need to use separate columns (and systems) to determine both anionic and cationic pesticides from a sample. The Luna Polar...
PR Newswire
20/07/2023

Abrasives Market to Reach $67.0 Billion, Globally, by 2032 at 4.7% CAGR: Allied…

Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/2155 Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/2155 Prime determinants of growth The global abrasives market is driven by an increase in demand from building and construction sector, proliferation of construction and infrastructure projects, infrastructure development in emerging economies, rising renovation and maintenance activities in the construction sector. However,...
PR Newswire
20/07/2023

Label-free Detection Market worth $863 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593 Browse in-depth TOC on "Label-free Detection Market" 193 - Tables 43 - Figures 252 - Pages Label-free Detection Market Scope: The instrument segment accounted for the largest share, by product & service in the label-free detection market in 2022. By type, the...
PR Newswire
20/07/2023

Revolutionary Anti-Aging Market Expected to Reach USD 422.81 Billion Valuation…

Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/anti-aging-market Report Link with All Related Graphs & Charts:https://www.fnfresearch.com/anti-aging-market Anti-Aging Market: Overview The industry is run by players and stakeholders that deal with the production or sale of products and services that are expected to either prevent, slow down, or reverse the visible signs of aging. Some of the products include topical creams like moisturizers, sun...
PR Newswire
20/07/2023

Lawn and Garden Watering Equipment Market to Reach $40.9 Billion, Globally, by…

Download Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/8286 Download Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/8286 Prime Determinants of Growth: The global lawn and garden watering equipment market is driven by factors such as an increase in demand for water-efficient products and the growth in popularity of gardening. However, global water shortages and limited availability of green spaces are restraining market...
PR Newswire
20/07/2023

Patient Engagement Solutions Market Size to Expand Lucratively and Reach $42.43…

Request for Sample Pages:https://www.insightaceanalytic.com/request-sample/1910 Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1910 Patient Engagement Solutions involve innovative healthcare technologies that connect clinicians, patients, payers, and partners in differentiated ways. The patient engagement solutions allow access to patient data anytime, anywhere, which aids in delivering high-quality and sustainable healthcare for all. Patient engagement...
PR Newswire
20/07/2023

Promontory Therapeutics Expands Phase 2 Trial of PT-112 in Metastatic…

The Phase 2, open-label, multi-center proof of concept study has the objective of characterizing the benefit-risk ratio and selecting the optimal dose regimen for pivotal development of PT-112, in line with the FDA's Project Optimus. In addition to proof of concept via safety and efficacy findings among late-stage metastatic patients, the study aims to generate meaningful supportive data via correlative research, for example on immune activation by PT-112 monotherapy, and by examining…
PR Newswire
20/07/2023

Amarin Board of Directors Announces Executive Compensation Program for New…

– Agreement Underscores Board's Commitment to Aligning Executive Compensation with Shareholder Returns – DUBLIN, Ireland and BRIDGEWATER, N.J., July20, 2023(GLOBE NEWSWIRE) -- Today the Board of Directors of Amarin Corporation plc (NASDAQ: AMRN) announced details regarding the compensation program for the Company's new President and Chief Executive Officer (CEO), Patrick Holt, who was appointed to the role on July 18, 2023.Under the terms of the agreement, the vast majority of Mr...
Nasdaq GlobeNewswire
20/07/2023

ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED…

Advances in Treatments, Clinical Trial ResultsThe Alzheimer's Association highlighted results from trials of drug and non-drug interventions for Alzheimer's disease at AAIC 2023. Advances in Treatments, Clinical Trial ResultsThe Alzheimer's Association highlighted results from trials of drug and non-drug interventions for Alzheimer's disease at AAIC 2023. New, more complete data were reported at AAIC 2023 by Eli Lilly from the TRAILBLAZER-ALZ 2 Phase 3 clinical trial of donanemab in...
PR Newswire
20/07/2023

PRODUCTLIFE GROUP ACQUIRES RNI, EXPANDING ITS SCIENTIFIC AND REGULATORY OFFERING…

Co-founded in 2006 by Violaine Chaumont, RNI delivers a comprehensive scope of regulatory services, including development strategy, scientific and toxicology expertise, due diligence work and quality audits. With an international understanding of regulations, RNI's team supports and advises nutraceutical, cosmetics, pharmaceutical, medical devices, active ingredient, and food companies to reach full market approval for their products. The company benefits from a unique regulatory and case law…
PR Newswire
20/07/2023

Endo Announces First Patient Enrolled in Registry of Peyronie's Disease

"We're pleased to help advance knowledge of Peyronie's disease and treatments so that, in the future, patients can benefit from a fuller understanding of their options," said Gregory Kaufman, M.D., Vice President, Medical Affairs and Chief Medical Officer at Endo. "Along with our study steering committee partners, Endo is committed to supporting the Peyronie's patient community." "We're pleased to help advance knowledge of Peyronie's disease and treatments so that, in…
PR Newswire
20/07/2023

PolyU awarded RGC Strategic Topics Grant to address societal needs in mental…

The PolyU project introduces an innovative and integrated strategy that utilises artificial intelligence (AI) and genomic and biomedical technology to support diagnosis, treatment planning and understanding of disease mechanisms. The project has been funded under the STG topic of using AI to address imminent challenges in healthcare, proposing an AI-based, data-driven approach to diagnosis and personalised therapy. The PolyU project introduces an innovative and integrated strategy that…
PR Newswire
20/07/2023

Smoke Evacuation System Market to be Worth $337.5 Million by 2030: Grand View…

Read 133-page market research report, "Smoke Evacuation System Market Size, Share & Trends Analysis Report By Product (Smoke Evacuating System, Smoke Evacuation Filters), By End-use (ASCs, Hospitals), By Application, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 133-page market research report, " Smoke Evacuation System Market Size, Share & Trends Analysis Report By Product (Smoke Evacuating System, Smoke Evacuation Filters), By…
PR Newswire
20/07/2023
Altri  Comunicati